Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chonghai Zhang

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Letters|March 16, 2024
Engineered bacteria in tumor immunotherapyHua Chen, Yinrui Zhu, Chonghai Zhang, et al.
Biomaterials|May 7, 2025
A novel radio-immunotherapy strategy: Gut microbiota metabolite combined with radioactive hydrogel for the treatment of low rectal cancerChonghai Zhang, Wenhao Shen, Zhifang Leng, et al.
Environmental Pollution (Barking, Essex : 1987)|September 15, 2019
BDE-209 induces male reproductive toxicity via cell cycle arrest and apoptosis mediated by DNA damage response signaling pathwaysXiangyang Li, Yupeng Zhu, Chonghai Zhang, et al.
ACS Applied Materials & Interfaces|May 9, 2025
Engineering <i>Escherichia coli</i> Nissle 1917 Carrying PD1 Agonists Resolves Intestinal Inflammation via Local Immune ModulationMengyuan Hu, Tingting Li, Mengmeng Xu, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 7, 2023
Nanozyme-Coated Bacteria Hitchhike on CD11b<sup>+</sup> Immune Cells to Boost Tumor RadioimmunotherapyHanghang Li, Pei Pei, Qing He, et al.
ACS Nano|November 21, 2023
A Polymeric Hydrogel to Eliminate Programmed Death-Ligand 1 for Enhanced Tumor Radio-ImmunotherapyWenhao Shen, Pei Pei, Chonghai Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 4, 2026
Engineered Bacteria-Vesicle Delivered Lactate Reprogramming Boosts Tumor RadiosensitivityFei Peng, Zhe Lei, Zhehao Zhang, et al.
Acta Pharmaceutica Sinica. B|November 28, 2025
Engineered <i>Escherichia coli Nissle</i> 1917 targeted delivery of extracellular PD-L1-mFc fragment for treating inflammatory bowel diseaseYuhong Wang, Lin Hu, Lei Wang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Letters|March 16, 2024
Engineered bacteria in tumor immunotherapyHua Chen, Yinrui Zhu, Chonghai Zhang, et al.
Biomaterials|May 7, 2025
A novel radio-immunotherapy strategy: Gut microbiota metabolite combined with radioactive hydrogel for the treatment of low rectal cancerChonghai Zhang, Wenhao Shen, Zhifang Leng, et al.
Environmental Pollution (Barking, Essex : 1987)|September 15, 2019
BDE-209 induces male reproductive toxicity via cell cycle arrest and apoptosis mediated by DNA damage response signaling pathwaysXiangyang Li, Yupeng Zhu, Chonghai Zhang, et al.
ACS Applied Materials & Interfaces|May 9, 2025
Engineering <i>Escherichia coli</i> Nissle 1917 Carrying PD1 Agonists Resolves Intestinal Inflammation via Local Immune ModulationMengyuan Hu, Tingting Li, Mengmeng Xu, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 7, 2023
Nanozyme-Coated Bacteria Hitchhike on CD11b<sup>+</sup> Immune Cells to Boost Tumor RadioimmunotherapyHanghang Li, Pei Pei, Qing He, et al.
ACS Nano|November 21, 2023
A Polymeric Hydrogel to Eliminate Programmed Death-Ligand 1 for Enhanced Tumor Radio-ImmunotherapyWenhao Shen, Pei Pei, Chonghai Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 4, 2026
Engineered Bacteria-Vesicle Delivered Lactate Reprogramming Boosts Tumor RadiosensitivityFei Peng, Zhe Lei, Zhehao Zhang, et al.
Acta Pharmaceutica Sinica. B|November 28, 2025
Engineered <i>Escherichia coli Nissle</i> 1917 targeted delivery of extracellular PD-L1-mFc fragment for treating inflammatory bowel diseaseYuhong Wang, Lin Hu, Lei Wang, et al.
Pageof 1